NVAX vs. AMGN
NVAX (Novavax, Inc.) and AMGN (Amgen Inc.) are both stocks. Both are in the Healthcare sector — NVAX in Biotechnology, AMGN in Drug Manufacturers - General. Over the past 10 years, NVAX returned -25.83%/yr vs 12.21%/yr for AMGN. Their 0.21 correlation means their historical movements had little consistent relationship.
Performance
NVAX vs. AMGN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVAX achieves a 14.58% return, which is significantly lower than AMGN's 26.41% return. Over the past 10 years, NVAX has underperformed AMGN with an annualized return of -25.83%, while AMGN has yielded a comparatively higher 12.21% annualized return.
NVAX
- 1D
- 0.52%
- 1M
- -17.65%
- 6M
- -6.89%
- YTD
- 14.58%
- 1Y
- 14.41%
- 3Y*
- -1.51%
- 5Y*
- -47.33%
- 10Y*
- -25.83%
- ALL TIME*
- -7.79%
AMGN
- 1D
- 4.57%
- 1M
- 11.30%
- 6M
- 12.99%
- YTD
- 26.41%
- 1Y
- 39.99%
- 3Y*
- 22.50%
- 5Y*
- 15.71%
- 10Y*
- 12.21%
- ALL TIME*
- 22.99%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
AMGN Amgen Inc. | $1.25B | $974.47M | $972.35M |
NVAX Novavax, Inc. | $22.26M | $25.69M | $41.53M |
NVAX vs. AMGN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVAX Novavax, Inc. | 14.58% | -16.42% | 67.50% | -53.31% | -92.81% | 28.30% | 2,701.76% | -89.18% | 48.39% | -1.59% |
AMGN Amgen Inc. | 26.41% | 29.67% | -6.77% | 13.46% | 20.43% | 0.87% | -1.99% | 27.60% | 15.23% | 22.27% |
Correlation
The correlation between NVAX and AMGN is 0.28, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.28 |
Correlation (3Y) Balances recent behavior with more history. | 0.24 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.22 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.22 |
Correlation (All Time) Calculated using the full available price history since Dec 13, 1995 | 0.21 |
Fundamentals
NVAX:
$1.27B
AMGN:
$220.11B
NVAX:
-$0.53
AMGN:
$16.09
NVAX:
2.15
AMGN:
5.81
NVAX:
$596.34M
AMGN:
$38.13B
NVAX:
$504.72M
AMGN:
$27.70B
NVAX:
-$57.01M
AMGN:
$12.73B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVAX vs. AMGN — Risk / Return Rank
NVAX
AMGN
NVAX vs. AMGN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novavax, Inc. (NVAX) and Amgen Inc. (AMGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVAX | AMGN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.24 | ||
| Sortino ratioReturn per unit of downside risk | -1.42 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.27 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | 0.40 | 2.43 | -2.02 |
| Martin ratioReturn relative to average drawdown | 0.70 | 5.80 | -5.09 |
Loading charts...
Drawdowns
NVAX vs. AMGN - Drawdown Comparison
The maximum NVAX drawdown since its inception was -98.82%, which is greater than AMGN's maximum drawdown of -63.48%. Use the drawdown chart below to compare losses from any high point for NVAX and AMGN.
Loading charts...
Drawdown Indicators
| NVAX | AMGN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.82% | -63.48% | -35.34% |
Max Drawdown (1Y)Largest decline over 1 year | -35.94% | -16.57% | -19.37% |
Max Drawdown (3Y)Largest decline over 3 years | -74.11% | -22.74% | -51.37% |
Max Drawdown (5Y)Largest decline over 5 years | -98.61% | -24.86% | -73.75% |
Max Drawdown (10Y)Largest decline over 10 years | -98.82% | -24.86% | -73.96% |
Current DrawdownCurrent decline from peak | -97.59% | 0.00% | -97.59% |
Average DrawdownAverage peak-to-trough decline | -70.89% | -16.74% | -54.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.50% | 7.04% | +13.46% |
Volatility
NVAX vs. AMGN - Volatility Comparison
Novavax, Inc. (NVAX) has a higher volatility of 10.84% compared to Amgen Inc. (AMGN) at 8.70%. This indicates that NVAX's price experiences larger fluctuations and is considered to be riskier than AMGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVAX | AMGN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.84% | 8.70% | +2.14% |
Volatility (6M)Calculated over the trailing 6-month period | 46.13% | 19.97% | +26.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.35% | 27.76% | +40.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 105.24% | 24.17% | +81.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 115.51% | 24.98% | +90.53% |
Dividends
NVAX vs. AMGN - Dividend Comparison
NVAX has not paid dividends to shareholders, while AMGN's dividend yield for the trailing twelve months is around 2.40%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMGN Amgen Inc. | 2.40% | 2.91% | 3.45% | 2.96% | 2.95% | 3.13% | 2.78% | 2.41% | 2.71% | 2.65% | 2.74% | 1.95% |
NVAX Novavax, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NVAX vs. AMGN - Financials Comparison
This section allows you to compare key financial metrics between Novavax, Inc. and Amgen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVAX vs. AMGN - Profitability Comparison
NVAX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Novavax, Inc. reported a gross profit of 108.82M and revenue of 139.51M. Therefore, the gross margin over that period was 78.0%.
AMGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Amgen Inc. reported a gross profit of 7.24B and revenue of 10.05B. Therefore, the gross margin over that period was 72.0%.
NVAX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Novavax, Inc. reported an operating income of -15.43M and revenue of 139.51M, resulting in an operating margin of -11.1%.
AMGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Amgen Inc. reported an operating income of 3.51B and revenue of 10.05B, resulting in an operating margin of 35.0%.
NVAX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Novavax, Inc. reported a net income of -9.49M and revenue of 139.51M, resulting in a net margin of -6.8%.
AMGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Amgen Inc. reported a net income of 2.38B and revenue of 10.05B, resulting in a net margin of 23.6%.
Frequently Asked Questions
NVAX and AMGN have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVAX has higher volatility (10.84%) compared to AMGN (8.70%). In terms of maximum drawdown, NVAX dropped -98.82% vs AMGN's -63.48%.
AMGN currently has the higher Sharpe Ratio (1.45 vs 0.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVAX and AMGN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer